The €308M Signal: Why a Record Funding Round in Germany Signals a New Dawn for Biotech
In a financial climate that has been defined by caution and correction, a thunderous signal just echoed across the European biotech landscape. German innovator Tubulis GmbH, a company at the forefront of cancer therapy, has closed a €308 million ($361 million) Series C financing round. Led by the globally respected Venrock Healthcare Capital Partners, this […]